Tuang joined Foresite in 2022 as an Investment Analyst on the Investment team and focuses on evaluating investment opportunities in private and public biotech companies.
Prior to joining Foresite, Tuang was an Associate Research Analyst at Eventide Asset Management, where he focused on investments in small and mid-capitalization biotechnology equities across multiple therapeutic areas. He attended the Harvard/MIT MD-PhD program under the Medical Scientist Training Program (MSTP) where he received Ph.D. in Chemical Biology from MIT in 2019 and M.D. from Harvard Medical School (HST program) in 2021. During his training, he received the David H. Koch Graduate Fellowship in Cancer Research and was named Amgen Scholars “Ten To Watch.” He is also a recipient of the Paul & Daisy Soros Fellowship for New Americans. He attended MIT as an undergraduate, receiving a B.S. in Chemistry in 2014.
